Armistice Capital, LLC Io Biotech, Inc. Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.17 - $1.71 $209,430 - $306,090
-179,000 Reduced 10.38%
1,545,000 $1.81 Million
Q1 2024

May 15, 2024
SELL
$1.48 - $1.99 $296,000 - $398,000
-200,000 Reduced 10.4%
1,724,000 $2.98 Million
Q4 2023

Feb 13, 2024
SELL
$0.84 - $1.95 $188,160 - $436,800
-224,000 Reduced 10.43%
1,924,000 $3.62 Million
Q3 2023

Nov 14, 2023
BUY
$1.28 - $2.03 $2.75 Million - $4.36 Million
2,148,000 New
2,148,000 $3.03 Million

Others Institutions Holding IOBT

# of Institutions
20
Shares Held
23.6M
Call Options Held
0
Put Options Held
0
View Full List

About IO Biotech, Inc.

IOBT Quotes by TradingView
  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $22.2M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email